-
摘要: 从泌尿外科医师的角度对于目前肾癌局部消融治疗进行综述,主要关注目前肾癌局部消融治疗方式如射频消融、微波消融、冷冻消融和不可逆电穿孔技术,总结它们各自的安全性和肿瘤学效果以及存在的挑战和不足。帮助泌尿外科医师对于小肾癌的局部消融治疗有一个清晰认识,从而帮助患者选择更加合适治疗方式。Abstract: This paper presented a review of focal ablation in the management of small renal masses from urologists' perspective and covered the evidence for current major ablation technology in safety and oncological outcomes, such as radiofrequency ablation(RFA), microwave ablation(MWA), cryoablation and irreversible electroporation(IRE) as well as areas of challenge requiring further research and clinical evaluation. This paper may help urologists clearly recognize local ablative therapy in small renal mass and make a wise choice for their patients.
-
Key words:
- renal cell carcinoma /
- focal ablation /
- treatment
-
-
[1] Ljungberg B,Albiges L,Bensalah K,et al.EAU guidelines on renal cell carcinoma:2017 update[J].Eur Urol,2017,67:913-924.
[2] Thompson RH,Boorjian SA,Lohse CM, et al.Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy[J].J Urol,2008,179(2):468-471;discussion 472-463.
[3] Capitanio U,Terrone C,Antonelli A,et al.Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function[J].Eur Urol,2015,67(4):683-689.
[4] Campbell S,Uzzo RG,Allaf ME,et al.Renal Mass and Localized Renal Cancer:AUA Guideline[J].J Urol,2017,198(3):520-529.
[5] Finelli A,Ismaila N,Bro B,et al.Management of small renal masses:American Society of Clinical Oncology clinical practice guideline[J].J Clin Oncol,2017,20:668-680.
[6] Motzer RJ,Jonasch E,Agarwal N,et al.Kidney Cancer,Version 2.2017,NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2017,15(6):804-834.
[7] Psutka SP,Feldman AS,McDougal WS,et al.Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma[J].Eur Urol,2013,63(3):486-492.
[8] Olweny EO,Park SK,Tan YK,et al.Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma:comparable oncologic outcomes at a minimum of 5 years of follow-up[J].Eur Urol,2012,61(6):1156-1161.
[9] Zagoria RJ,Pettus JA,Rogers M,et al.Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma[J].Urology,2011,77(6):1393-1397.
[10] Marshall HR,Shakeri S,Hosseiny M,et al.Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients[J].J Vasc Interv Radiol,2020,31(1):15-24.
[11] Pantelidou M,Challacombe B,McGrath A,et al.Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma[J].Cardiovasc Intervent Radiol,2016,39(11):1595-1603.
[12] Best SL,Park SK,Youssef RF,et al.Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter:size matters[J].J Urol,2012,187(4):1183-1189.
[13] Taneja SS,Shah O.Taneja’s Complications of urologic surgery:diagnosis,prevention,and management[M].Fifth edition.New York:Elsevier.2018:Complications of renal tissue ablation:237-243.
[14] TM Wah.Image-guided ablation of renal cell carcinoma[J].Clin Radiol,2017,72(8):636-644.
[15] Breen DJ,Bryant TJ,Abbas A,et al.Percutaneous cryoablation of renal tumours:outcomes from 171 tumours in 147 patients[J].BJU Int,2013,112(6):758-765.
[16] Guazzoni G,Cestari A,Buffi N,et al.Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors:8 years of experience in a single institution[J].Urology,2010,76:624-629.
[17] Georgiades CS,Rodriguez R.Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma:results of a prospective,single-arm,5-year study[J].Cardiovasc Intervent Radiol,2014,37(6):1494-1499.
[18] Caputo PA,Zargar H,Ramirez D,et al.Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors:A Matched Group Comparative Analysis[J].Eur Urol,2017,71(1):111-117.
[19] Salagierski M,Wojciechowska A,Zajac K,et al.The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses[J].Eur Urol Oncol,2018,1(5):395-402.
[20] Zondervan PJ,Buijs M,De Bruin DM,et al.Available ablation energies to treat cT1 renal cell cancer:emerging technologies[J].World J Urol,2019,37(3):445-455.
[21] Guan W,Bai J,Liu J,et al.Microwave ablation versus partial nephrectomy for small renal tumors:intermediate-term results[J].J Surg Oncol,2012,106(3):316-321.
[22] Wendler JJ,Porsch M,Nitschke S,et al.A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation(IRE)ablation by NanoKnife in patients with localised renal cell carcinoma(RCC)with delayed interval tumour resection(IRENE trial)[J].Contemp Clin Trials,2015,43:10-9.
[23] Diehl SJ,Rathmann N,Kostrzewa M,et al.Irreversible Electroporation for Surgical Renal Masses in Solitary Kidneys:Short-Term Interventional and Functional Outcome[J].J Vasc Interv Radiol,2016,27(9):1407-1413.
[24] Nielsen K,Scheffer HJ,Vieveen JM,et al.Anaesthetic management during open and percutaneous irreversible electroporation[J].Br J Anaesth,2014,113(6):985-992.
[25] Siva S,Kothari G,Muacevic A,et al.Radiotherapy for renal cell carcinoma:renaissance of an overlooked approach[J].Nat Rev Urol,2017,14(9):549-563.
[26] Houston Thompson R,Atwell T,Schmit G,et al.Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses[J].Eur Urol,2015,67:252-259.
[27] Hickey RM,Kulik LM,Nimeiri H,et al.Immuno-oncology and Its Opportunities for Interventional Radiologists:Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures[J].J Vasc Interv Radiol,2017,28(11):1487-1494.
-
计量
- 文章访问数: 315
- PDF下载数: 266
- 施引文献: 0
下载: